Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet ®), Viaminate and Concomitant Conventional Therapies: A Retrospective Study.

Conclusion: Our results showed that the incorporation of Viaminate and Daivobet® into mainstay treatment was effective and safe for the long-term management of RHE. PMID: 33149651 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33149651?dopt=Abstract

Source: Clinical, Cosmetic and Investigational Dermatology - November 6, 2020 Category: Dermatology Tags: Clin Cosmet Investig Dermatol Source Type: research